Information about Medicine:
Amitiza, or Lubiprostone, is primarily prescribed to treat chronic idiopathic constipation (CIC) in adults and irritable bowel syndrome with constipation (IBS-C) in women aged 18 years and older.
Lubiprostone, a chloride channel activator, is the active pharmaceutical ingredient in Amitiza. It works by increasing intestinal fluid secretion, thereby promoting bowel movement.
Product Highlights
- Helps relieve symptoms associated with chronic constipation by increasing fluid secretion in the intestines, facilitating bowel movements.
- Also aids in reducing abdominal discomfort and bloating commonly experienced with IBS-C.
Key Ingredients
Key Benefits
- Eases chronic constipation by enhancing intestinal fluid secretion.
- Alleviates symptoms such as hard stools, straining during bowel movements, and abdominal discomfort.
- Provides relief from bloating and improves overall bowel function.
Direction For Use
- Amitiza is typically taken orally with food and water.
- The usual dosage for chronic constipation is 24 mcg twice daily.
- For IBS-C, the recommended dosage is 8 mcg twice daily.
Safety Concern
- Common side effects are nausea, diarrhea, abdominal pain, and headache.
- It is not recommended for use in patients with severe diarrhea or bowel obstruction.
- Pregnant women should use Amitiza with caution, as its safety during pregnancy has not been fully established.
Avoid Taking Amitiza (Lubiprostone) If:
- You are allergic to lubiprostone or any other ingredients in Amitiza.
- You have severe diarrhea or a bowel obstruction.
- You are pregnant or breastfeeding without consulting your healthcare provider.
